Clinical Trial Update: Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia [Phase 2]

View source ↗

Summary

Ongoing Phase 2 clinical trial evaluating the long-term efficacy and safety of Orlistat for hyperlipoproteinemia Type I, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia Type

Drugs mentioned

• Orlistat (orlistat)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 1 Hyperlipoprotenemia | Phase 2 | Status: RECRUITING